Fungicide-tolerant persister formation during cryptococcal pulmonary infection

Cell Host Microbe. 2024 Feb 14;32(2):276-289.e7. doi: 10.1016/j.chom.2023.12.012. Epub 2024 Jan 11.

Abstract

Bacterial persisters, a subpopulation of genetically susceptible cells that are normally dormant and tolerant to bactericides, have been studied extensively because of their clinical importance. In comparison, much less is known about the determinants underlying fungicide-tolerant fungal persister formation in vivo. Here, we report that during mouse lung infection, Cryptococcus neoformans forms persisters that are highly tolerant to amphotericin B (AmB), the standard of care for treating cryptococcosis. By exploring stationary-phase indicator molecules and developing single-cell tracking strategies, we show that in the lung, AmB persisters are enriched in cryptococcal cells that abundantly produce stationary-phase molecules. The antioxidant ergothioneine plays a specific and key role in AmB persistence, which is conserved in phylogenetically distant fungi. Furthermore, the antidepressant sertraline (SRT) shows potent activity specifically against cryptococcal AmB persisters. Our results provide evidence for and the determinant of AmB-tolerant persister formation in pulmonary cryptococcosis, which has potential clinical significance.

Keywords: Cryptococcus neoformans; ergothioneine; persisters; stationary phase.

MeSH terms

  • Amphotericin B / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antifungal Agents / pharmacology
  • Cryptococcosis* / drug therapy
  • Cryptococcosis* / microbiology
  • Cryptococcus neoformans*
  • Fungicides, Industrial* / pharmacology
  • Mice
  • Pneumonia* / drug therapy
  • Pneumonia* / microbiology

Substances

  • Amphotericin B
  • Anti-Bacterial Agents
  • Antifungal Agents
  • Fungicides, Industrial